IP Library Granted Patent US 9,890,368
Granted Patent B2
US 9,890,368 · App. 14/519,525 · Granted Feb 13, 2018

Polypeptide fragments comprising endonuclease activity and their use

Inventors: Denis Bouvier (Meylan, FR); Thibaut Crepin (Grenoble, FR); Rob Ruigrok (Sassenage, FR); Aelxander Dias (Voiron, FR); Stephen Cusack (Seyssinet-Pariset, FR)
Assignees: European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique; Universite Grenoble Alpes
C12N9/22A61K31/192C12N9/127C12Q1/44G06F19/12G06F19/16C07K2299/00G01N2333/922G01N2500/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,890,368
App. No.
14/519,525
Granted
Feb 13, 2018
Kind
B2
Abstract

The present invention relates to polypeptide fragments comprising an amino-terminal fragment of the PA subunit of a viral RNA-dependent RNA polymerase or variants thereof possessing endonuclease activity, wherein said PA subunit is from a virus belonging to the Orthomyxoviridae family. This invention also relates to (i) crystals of the polypeptide fragments which are suitable for structure determination of said polypeptide fragments using X-ray crystallography and (ii) computational methods using the structural coordinates of said polypeptide to screen for and design compounds that modulate, preferably inhibit the endonucleolytically active site within the polypeptide fragment. In addition, this invention relates to methods identifying compounds that bind to the PA polypeptide fragments possessing endonuclease activity and preferably inhibit said endonucleolytic activity, preferably in a high throughput setting. This invention also relates to compounds and pharmaceutical compositions comprising the identified compounds for the treatment of disease conditions due to viral infections caused by viruses of the Orthomyxoviridae family.

Claims (32)

1. An isolated polynucleotide encoding a polypeptide consisting of:

a)

i. amino acids 1 to 209 of the amino acid sequence of SEQ ID NO: 2 or a fragment thereof consisting of at least amino acids 15 to 196 of the amino acid sequence of SEQ ID NO: 2, or a variant consisting of at least 95% amino acid sequence identity to amino acids 1 to 209 of the amino acid sequence of SEQ ID NO: 2, or a fragment thereof consisting of at least 95 % amino acid sequence identity to amino acids 15 to 196 of the amino acid sequence of SEQ ID NO: 2,

ii. amino acids 1 to 206 of the amino acid sequence of SEQ ID NO: 4 or a fragment thereof consisting of at least amino acids 15 to 195 of the amino acid sequence of SEQ ID NO: 4, or a variant consisting of at least 95% amino acid sequence identity to amino acids 1 to 206 of the amino acid sequence of SEQ ID NO: 4, or a fragment thereof consisting of at least 95% amino acid sequence identity to amino acids 15 to 195 of the amino acid sequence of SEQ ID NO: 4, or

iii. amino acids 1 to 189 of the amino acid sequence of SEQ ID NO: 6 or a fragment thereof consisting of at least amino acids 15 to 178 of the amino acid sequence of SEQ ID NO: 6, or a variant consisting of at least 95% amino acid sequence identity to amino acids 1 to 189 of the amino acid sequence of SEQ ID NO: 6, or a fragment thereof consisting of at least 95% amino acid sequence identity to amino acids 15 to 178 of the amino acid sequence of SEQ ID NO: 6,

wherein said polypeptide has endonuclease activity of a PA subunit of a viral RNA-dependent RNA polymerase, and

b)

i. a protease recognition site with or without an amino acid linker, and

ii. a heterologous peptide or heterologous protein tag.

2. A recombinant vector comprising said isolated polynucleotide of claim 1 .

3. A recombinant host cell comprising said isolated polynucleotide of claim 1 .

4. The isolated polynucleotide of claim 1 , wherein said polypeptide encoded by said isolated polynucleotide consists of amino acids 1 to 209 of the amino acid sequence set forth in SEQ ID NO: 2 linked to the amino acid sequence of SEQ ID NO: 19.

5. The isolated polynucleotide of claim 1 , wherein said protease recognition site is a thrombin, Factor Xa, PreScission or TEV protease recognition site.

6. The isolated polynucleotide of claim 1 , wherein said protease recognition site is the amino acid sequence of SEQ ID NO: 23.

7. The isolated polynucleotide of claim 6 , wherein said protease recognition site is the amino acid sequence of SEQ ID NO: 21.

8. The isolated polynucleotide of claim 1 , wherein said amino acid linker is the amino acid sequence of SEQ ID NO: 19.

9. The isolated polynucleotide of claim 1 , wherein said heterologous peptide or heterologous protein tag is a tag that facilitates purification or detection of the polypeptide.

10. The isolated polynucleotide of claim 1 , wherein said heterologous peptide or heterologous protein tag is selected from the group consisting of hemagglutinin-tag, FLAG-tag, myc-tag, poly-His-tag, glutathione-S-transferase-tag, maltose-binding-protein-tag, NusA-tag, thioredoxin-tag, and a fluorescent protein-tag.

11. The isolated polynucleotide of claim 10 , wherein said fluorescent protein-tag is selected from the group consisting of a green fluorescent protein, a yellow fluorescent protein, a red fluorescent protein, and a cyan fluorescence protein.

12. An isolated polynucleotide encoding a polypeptide consisting of:

a)

i. amino acids 1 to 209 of the amino acid sequence of SEQ ID NO: 2 or a fragment thereof consisting of at least amino acids 15 to 196 of the amino acid sequence of SEQ ID NO: 2, or a variant consisting of at least 95% amino acid sequence identity to amino acids 1 to 209 of the amino acid sequence of SEQ ID NO: 2, or a fragment thereof consisting of at least 95% amino acid sequence identity to amino acids 15 to 196 of the amino acid sequence of SEQ ID NO: 2,

ii. amino acids 1 to 206 of the amino acid sequence of SEQ ID NO: 4 or a fragment thereof consisting of at least amino acids 15 to 195 of the amino acid sequence of SEQ ID NO: 4, or a variant consisting of at least 95% amino acid sequence identity to amino acids 1 to 206 of the amino acid sequence of SEQ ID NO: 4, or a fragment thereof consisting of at least 95% amino acid sequence identity to amino acids 15 to 195 of the amino acid sequence of SEQ ID NO: 4 or

iii. amino acids 1 to 189 of the amino acid sequence of SEQ ID NO: 6 or a fragment thereof consisting of at least amino acids 15 to 178 of the amino acid sequence of SEQ ID NO: 6, or a variant consisting of at least 95% amino acid sequence identity to amino acids 1 to 189 of the amino acid sequence of SEQ ID NO: 6, or a fragment thereof consisting of at least 95% amino acid sequence identity to amino acids 15 to 178 of the amino acid sequence of SEQ ID NO: 6,

wherein said polypeptide has endonuclease activity of a PA subunit of a viral RNA-dependent RNA polymerase, and

a heterologous peptide or heterologous protein tag.

13. A recombinant vector comprising said isolated polynucleotide of claim 12 .

14. A recombinant host cell comprising said isolated polynucleotide of claim 12 .

15. The isolated polynucleotide of claim 12 , wherein said polypeptide encoded by said isolated polynucleotide consists of amino acids 1 to 209 of the amino acid sequence set forth in SEQ ID NO: 2 linked to the amino acid sequence of SEQ ID NO: 19.

16. The isolated polynucleotide of claim 12 , wherein said heterologous peptide or heterologous protein tag is a tag that facilitates purification or detection of the polypeptide.

17. The isolated polynucleotide of claim 12 , wherein said heterologous peptide or heterologous protein tag is selected from the group consisting of hemagglutinin-tag, FLAG-tag, myc-tag, poly-His-tag, glutathione-S-transferase-tag, maltose-binding-protein-tag, NusA-tag, thioredoxin-tag, and a fluorescent protein-tag.

18. The isolated polynucleotide of claim 17 , wherein said fluorescent protein-tag is selected from the group consisting of a green fluorescent protein, a yellow fluorescent protein, a red fluorescent protein, and a cyan fluorescence protein.

Assignments (5)
CHANGE OF NAME Recorded Oct 26, 2016
From: UNIVERSITY JOSEPH FOURIER
To: UNIVERSITE GRENOBLE ALPES
Reel/Frame 040142/0386 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2016
From: CREPIN, THIBAUT
To: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Reel/Frame 038878/0571 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2016
From: CUSACK, STEPHEN
To: EUROPEAN MOLECULAR BIOLOGY LABORATORY
Reel/Frame 038878/0606 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2016
From: RUIGROK, ROB; DIAS, ALEXANDER
To: UNIVERSITY JOSEPH FOURIER
Reel/Frame 038878/0609 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2016
From: BOUVIER, DENIS
To: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; UNIVERSITY JOSEPH FOURIER
Reel/Frame 038878/0619 →
Continuity (3)
Continuation 13140626
Provisional Application 61203259 · Dec 19, 2008
Related Publication 20150105315A1 · Apr 16, 2015